Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPOPTOSIS-MI: Dapagliflozin in Acute Myocardial Infarction
NCT06615674Phase 4Completed
- Start
- Sep 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in acute myocardial infarction (AMI). Started Sep 2024; status: completed.
02
Drugs
dapagliflozin
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT06615674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06615674.